238 related articles for article (PubMed ID: 34394069)
1.
Lei B; Sleiman MM; Cheng Q; Tu Z; Zhu P; Goddard M; Martins PN; Langerude L; Nadig S; Tomlinson S; Atkinson C
Front Immunol; 2021; 12():630581. PubMed ID: 34394069
[TBL] [Abstract][Full Text] [Related]
2. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
[TBL] [Abstract][Full Text] [Related]
3. Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts.
Atkinson C; Floerchinger B; Qiao F; Casey S; Williamson T; Moseley E; Stoica S; Goddard M; Ge X; Tullius SG; Tomlinson S
Circulation; 2013 Mar; 127(12):1290-9. PubMed ID: 23443736
[TBL] [Abstract][Full Text] [Related]
4. Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.
Cheng Q; Patel K; Lei B; Rucker L; Allen DP; Zhu P; Vasu C; Martins PN; Goddard M; Nadig SN; Atkinson C
Am J Transplant; 2018 Oct; 18(10):2417-2428. PubMed ID: 29504277
[TBL] [Abstract][Full Text] [Related]
5. Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling.
Lin C; Lei B; Dong C; Chen J; Chen S; Jiang K; Zeng Y; Su H; Jin H; Qiu X; Li Z; Hu Z; Yu S; Zhang C; Lu S; Atkinson C; Tomlinson S; Zhong F; Yuan G; He S
Am J Transplant; 2023 Apr; 23(4):484-497. PubMed ID: 36746335
[TBL] [Abstract][Full Text] [Related]
6. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
[TBL] [Abstract][Full Text] [Related]
7. Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation.
Atkinson C; He S; Morris K; Qiao F; Casey S; Goddard M; Tomlinson S
J Immunol; 2010 Dec; 185(11):7007-13. PubMed ID: 20962256
[TBL] [Abstract][Full Text] [Related]
8. A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice.
He S; Atkinson C; Qiao F; Cianflone K; Chen X; Tomlinson S
J Clin Invest; 2009 Aug; 119(8):2304-16. PubMed ID: 19620784
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation.
Zheng C; Ricci J; Zhang Q; Alawieh A; Yang X; Nadig S; He S; Engel P; Jin J; Atkinson C; Tomlinson S
Front Immunol; 2021; 12():785229. PubMed ID: 34899752
[TBL] [Abstract][Full Text] [Related]
10. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
Huang Y; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2008 Dec; 181(11):8068-76. PubMed ID: 19017999
[TBL] [Abstract][Full Text] [Related]
11. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
Atkinson C; Song H; Lu B; Qiao F; Burns TA; Holers VM; Tsokos GC; Tomlinson S
J Clin Invest; 2005 Sep; 115(9):2444-53. PubMed ID: 16127466
[TBL] [Abstract][Full Text] [Related]
12. Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia-Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation.
Wang X; O'Brien ME; Yu J; Xu C; Zhang Q; Lu S; Liang L; An X; McDyer JF; Mallampalli RK
Am J Respir Cell Mol Biol; 2019 Aug; 61(2):244-256. PubMed ID: 30742487
[TBL] [Abstract][Full Text] [Related]
13. Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.
Liu F; Wu L; Wu G; Wang C; Zhang L; Tomlinson S; Qin X
Atherosclerosis; 2014 May; 234(1):237-43. PubMed ID: 24685815
[TBL] [Abstract][Full Text] [Related]
14. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
[TBL] [Abstract][Full Text] [Related]
15. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
[TBL] [Abstract][Full Text] [Related]
16. Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: Clinical experience and experimental implications.
He J; Khan UZ; Qing L; Wu P; Tang J
Front Immunol; 2022; 13():998952. PubMed ID: 36189311
[TBL] [Abstract][Full Text] [Related]
17. Treatment with tetrahydrobiopterin overcomes brain death-associated injury in a murine model of pancreas transplantation.
Oberhuber R; Ritschl P; Fabritius C; Nguyen AV; Hermann M; Obrist P; Werner ER; Maglione M; Flörchinger B; Ebner S; Resch T; Pratschke J; Kotsch K
Am J Transplant; 2015 Nov; 15(11):2865-76. PubMed ID: 26104062
[TBL] [Abstract][Full Text] [Related]
18. Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope.
Zheng C; Sleiman MM; Yang X; He S; Atkinson C; Tomlinson S
J Heart Lung Transplant; 2021 Oct; 40(10):1112-1121. PubMed ID: 34334299
[TBL] [Abstract][Full Text] [Related]
19. Donor brain death leads to differential immune activation in solid organs but does not accelerate ischaemia-reperfusion injury.
Ritschl PV; Ashraf MI; Oberhuber R; Mellitzer V; Fabritius C; Resch T; Ebner S; Sauter M; Klingel K; Pratschke J; Kotsch K
J Pathol; 2016 May; 239(1):84-96. PubMed ID: 26890577
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
Park P; Haas M; Cunningham PN; Alexander JJ; Bao L; Guthridge JM; Kraus DM; Holers VM; Quigg RJ
J Am Soc Nephrol; 2001 Jul; 12(7):1383-1390. PubMed ID: 11423567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
